Official registry · BMU
Bangladesh Medical UniversityBMU CTR

The Registry Office does not review or approve the safety and science of the studies listed on this website.

Read our full disclaimer for details.

Screening Strategies for Cervical Cancer in Community Clinics

BDCTR ID
BDCTR-2026-000104
Sponsor
Bangladesh Medical University
Information provided by
Dr Rehana Begum (Responsible Party)
Last Update Posted
2026-08-22

Study Overview

Brief Summary

This trial compares HPV self-sampling with clinic-based visual inspection to improve cervical cancer screening uptake in community settings.

Detailed Description

Eligible women are randomised to offered HPV self-sampling or standard clinic-based screening. The primary endpoint is screening uptake within three months of invitation.

Official Title

HPV Self-sampling Versus Clinic-based Visual Inspection to Improve Cervical Cancer Screening Uptake

Conditions

  • Cervical Cancer
  • Cancer Screening

Intervention/Treatment

  • Diagnostic Test: HPV self-sampling kit
  • Procedure/Surgery: Visual inspection with acetic acid

Other Study ID Numbers

BMU-ONC-2026-003

Study Start

2026-07-20

Primary Completion

2027-04-30

Study Completion

2027-07-31

Enrollment (Estimated)

5,200

Study Type

Interventional

Phase

N/A

Contacts and Locations

This section provides contact details for people who can answer questions about joining this study, and information on where this study is taking place.

To learn more, please see the Contacts and Locations section in How to Read a Study Record.

Study Contact

Name: Dr Rehana Begum

Phone Number: +8802550000104

Email: cervical-screen@bmu.ac.bd

This study has 1 location

Bangladesh

  • Rajshahi, Rajshahi, Bangladesh, 6000

    Recruiting

    Rajshahi Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

<p>Inclusion Criteria:</p><ul><li>Women aged 30 to 60 years not screened in the past three years.</li></ul><p>Exclusion Criteria:</p><ul><li>Prior hysterectomy.</li></ul>

Ages Eligible for Study

30 Years to 60 Years (Adult)

Sexes Eligible for Study

Female

Accepts Healthy Volunteers

Yes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose:
Screening
Allocation:
Randomized
Interventional Model:
Parallel Assignment
Masking:
None (Open Label)

Arms and Interventions

Participant Group/ArmIntervention/Treatment

Experimental: HPV self-sampling

Diagnostic Test: HPV self-sampling kit

Active Comparator: Clinic-based screening

Procedure/Surgery: Visual inspection with acetic acid

What is the study measuring?

Primary Outcome Measures

Outcome MeasureMeasure DescriptionTime Frame
Screening uptake rate3 months from invitation

Secondary Outcome Measures

Outcome MeasureMeasure DescriptionTime Frame
Proportion referred for follow-up6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bangladesh Medical University

Study Record Dates

These dates track the progress of study record and summary results submissions to the registry. Study records and reported results are reviewed by the Registry Office to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted that Met QC Criteria

2026-07-18

First Posted

2026-07-18

Study Record Updates

Last Update Submitted that Met QC Criteria

2026-08-22

Last Update Posted

2026-08-22

Last Verified

2026-08

More Information

Record History

Terms related to this study

Keywords Provided by Bangladesh Medical University

  • cervical cancer
  • HPV
  • self-sampling
  • screening

Plan for Individual Participant Data (IPD)

Plan to Share Individual Participant Data (IPD)?

Not provided

Drug and device information, study documents, and helpful links

Data Monitoring Committee

No